HK1208371A1 - 用於治療視網膜變性的方法和組合物 - Google Patents

用於治療視網膜變性的方法和組合物

Info

Publication number
HK1208371A1
HK1208371A1 HK15109136.9A HK15109136A HK1208371A1 HK 1208371 A1 HK1208371 A1 HK 1208371A1 HK 15109136 A HK15109136 A HK 15109136A HK 1208371 A1 HK1208371 A1 HK 1208371A1
Authority
HK
Hong Kong
Prior art keywords
compositions
treatment
methods
retinal degeneration
retinal
Prior art date
Application number
HK15109136.9A
Other languages
English (en)
Inventor
．凱斯
．川西
．憲之
Original Assignee
Sanbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanbio Inc filed Critical Sanbio Inc
Publication of HK1208371A1 publication Critical patent/HK1208371A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15109136.9A 2012-10-09 2015-09-17 用於治療視網膜變性的方法和組合物 HK1208371A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261711665P 2012-10-09 2012-10-09
PCT/US2013/030983 WO2014058464A1 (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration

Publications (1)

Publication Number Publication Date
HK1208371A1 true HK1208371A1 (zh) 2016-03-04

Family

ID=48040427

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109136.9A HK1208371A1 (zh) 2012-10-09 2015-09-17 用於治療視網膜變性的方法和組合物

Country Status (11)

Country Link
US (2) US9326999B2 (zh)
EP (1) EP2906293B1 (zh)
JP (2) JP6267713B2 (zh)
KR (2) KR20150075082A (zh)
CN (1) CN104797264A (zh)
AU (2) AU2013330433B2 (zh)
CA (1) CA2885414C (zh)
HK (1) HK1208371A1 (zh)
IL (1) IL237772B (zh)
SG (2) SG11201502753YA (zh)
WO (1) WO2014058464A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6267713B2 (ja) 2012-10-09 2018-01-24 サンバイオ，インコーポレイティド 網膜変性処置のための方法および組成物
US10618963B2 (en) 2014-03-12 2020-04-14 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
US10519237B2 (en) 2014-03-12 2019-12-31 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
US10144778B2 (en) 2014-03-12 2018-12-04 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
PT3524429T (pt) 2014-07-31 2021-03-17 Unilin Bv Método para fabrico de um produto de revestimento de pavimento
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
JP7220149B2 (ja) 2016-12-28 2023-02-09 サンバイオ，インコーポレイティド 細胞送達システム及びその動作方法
WO2018170239A1 (en) 2017-03-15 2018-09-20 The Regents Of The University Of California Methods of treating lysosomal disorders
CN107519491B (zh) * 2017-09-04 2020-08-25 无锡市人民医院 Copb2抑制剂的用途
EP3953468A4 (en) * 2019-04-12 2023-01-11 The Regents of The University of California METHODS OF TREATING INHERITED OCULAR DEFECTS

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534743A (ja) * 2001-04-09 2004-11-18 ロランティス リミテッド ヘッジホッグ
JP3886346B2 (ja) 2001-06-22 2007-02-28 サンバイオ，インコーポレイティド 骨髄間質細胞由来Ｓｃｈｗａｎｎ細胞を含む神経再生用医薬組成物
WO2003012441A1 (en) * 2001-07-25 2003-02-13 Lorantis Limited Method for detecting modulators of notch signalling
AU2003207064B2 (en) 2002-02-06 2006-07-13 Sanbio, Inc. Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring Notch gene
GB0300428D0 (en) * 2003-01-09 2003-02-05 Lorantis Ltd Medical treatment
DK1737950T3 (da) 2004-04-12 2011-12-05 Sanbio Inc Celler, der udviser neuronal-progenitorcelle-karakteristika
WO2006096640A2 (en) 2005-03-07 2006-09-14 Sanbio Inc. Use of neuronal precursor cells for treatment of central nervous system lesions
EP2129775A1 (en) * 2007-02-12 2009-12-09 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
US8945919B2 (en) 2007-08-15 2015-02-03 San Bio, Inc. Methods and composition for treating neural degeneration
WO2009073178A1 (en) 2007-12-03 2009-06-11 Sanbio, Inc. Extracellular matrix from pluripotent cells
US20110306137A1 (en) 2007-12-03 2011-12-15 Irina Aizman Methods and compositions for modulating differentiation of pluripotential cells
ES2582559T3 (es) 2007-12-06 2016-09-13 Inserm - Institut National De La Santé Et De La Recherche Médicale Factor trófico para el tratamiento de las enfermedades degenerativas de la retina
PL2274430T3 (pl) 2008-04-30 2017-09-29 Sanbio Inc Komórki regenerujące nerwy ze zmianami w metylacji DNA
JP5562329B2 (ja) 2008-07-01 2014-07-30 エルエスアイ コーポレーション フラッシュ・メモリ・コントローラとフラッシュ・メモリ・アレイの間でインタフェースをとるための方法および装置
SI2307051T1 (sl) * 2008-07-08 2015-04-30 Oncomed Pharmaceuticals, Inc. Notch-vezavna sredstva in antagonisti ter postopki njihove uporabe
WO2010144696A1 (en) * 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
JP5852969B2 (ja) * 2010-02-26 2016-02-03 コーネル ユニヴァーシティー 人工網膜
ES2874953T3 (es) * 2010-07-23 2021-11-05 Astellas Inst For Regenerative Medicine Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células
WO2012034101A2 (en) * 2010-09-09 2012-03-15 The Regents Of The University Of California Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
US8785190B2 (en) 2011-04-06 2014-07-22 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP6306506B2 (ja) 2011-08-19 2018-04-04 サンバイオ，インコーポレイティド 神経原生及びグリア原生因子及びそれらについてのアッセイ
CN104254337A (zh) 2012-01-27 2014-12-31 桑比欧公司 用于调节血管生成和血管发生的方法和组合物
JP6134783B2 (ja) 2012-05-16 2017-05-24 サンバイオ，インコーポレイティド 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP6267713B2 (ja) 2012-10-09 2018-01-24 サンバイオ，インコーポレイティド 網膜変性処置のための方法および組成物
US20140219976A1 (en) 2012-10-09 2014-08-07 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration

Also Published As

Publication number Publication date
KR101906756B1 (ko) 2018-12-05
IL237772A0 (en) 2015-05-31
US20160271181A1 (en) 2016-09-22
CN104797264A (zh) 2015-07-22
CA2885414C (en) 2018-05-01
SG11201502753YA (en) 2015-05-28
KR20150075082A (ko) 2015-07-02
US9326999B2 (en) 2016-05-03
US9855299B2 (en) 2018-01-02
EP2906293A1 (en) 2015-08-19
CA2885414A1 (en) 2014-04-17
JP2015533122A (ja) 2015-11-19
WO2014058464A1 (en) 2014-04-17
AU2013330433B2 (en) 2016-06-16
AU2016213752A1 (en) 2016-08-25
AU2016213752B2 (en) 2017-11-23
US20140099291A1 (en) 2014-04-10
SG10201607176TA (en) 2016-10-28
JP6297648B2 (ja) 2018-03-20
IL237772B (en) 2019-10-31
JP6267713B2 (ja) 2018-01-24
EP2906293B1 (en) 2018-12-12
JP2016210813A (ja) 2016-12-15
AU2013330433A1 (en) 2015-04-02
KR20170133515A (ko) 2017-12-05

Similar Documents

Publication Publication Date Title
IL260585B (en) Preparations and methods for the treatment of diseases related to the retina of the eye
HK1210502A1 (zh) 用於治療遺傳性病狀的方法和組合物
HK1210968A1 (zh) 用於眼部疾病和病症的組合物和治療
HK1208371A1 (zh) 用於治療視網膜變性的方法和組合物
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
EP2776567A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF THE CYTOMEGALIA VIRUS
SG2014008080A (en) Methods of treatment of retinal degeneration diseases
EP2819687A4 (en) COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL VASCULAR DISEASE
DK3292875T3 (en) Compositions and methods for treating diseases
EP2691529A4 (en) METHOD AND COMPOSITIONS FOR TREATING BRAIN DISEASES
PL2814463T3 (pl) Okulistyczne kompozycje farmaceutyczne i sposoby ich wytwarzania i stosowania
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
EP2755668A4 (en) COMPOSITIONS OF HYR1 AND TREATMENT PROCEDURES THEREWITH
EP2670243A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLAUCOMA
EP2879495A4 (en) COMPOSITIONS AND METHODS OF TREATING NEUROPSYCHOLOGICAL DEFICIENCIES
EP2928456A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
EP2825184A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
EP3003341A4 (en) Compositions and methods for treatment of retinal degenerative diseases
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment